Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Kedudukan dalam Saham #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Harga Saham
$0.00185055
Modal Pasaran
$48.29K
Perubahan (1 hari)
-3.55%
Perubahan (1 tahun)
30.31%
Negara
GB
Perdagangan Nuformix plc (NFX)

Kategori

Nisbah P/S bagi Nuformix plc (NFX)
Nisbah P/S pada September 2026 TTM: 0.00
Menurut laporan kewangan dan harga saham terkini Nuformix plc, nisbah P/S semasa (TTM) ialah 0.00. Pada akhir 2024, nisbah P/S syarikat ialah 0.00.
Sejarah nisbah P/S untuk Nuformix plc dari 2014 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH